Interagency Patent Coordination and Improvement Act of 2025
Official title: A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes.
What Do You Think?
How would you vote?
Vote to see the result.
What Happened in Congress?
Not yet voted on the floor.
Where the Bill Stands
- Introduced, done
- Committee, done
- Floor Vote, current stage
- Outcome, not yet
What This Bill Does
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.
The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.
Sponsors
Related Documents
Timeline
- SenateCommittee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
- SenateCommittee on the Judiciary. Ordered to be reported with amendments favorably.
- Library of CongressIntroduced in Senate
- SenateRead twice and referred to the Committee on the Judiciary. (text: CR S1804-1805)
- Introduced
- Committee

Comments
Comments with insults, hate speech or personal information are removed.